Balloon-occluded retrograde transvenous obliteration with lauromacrogol sclerosant foam for gastric varices

作     者：Zhiyang Wu Wei Wu Cheng Tao Qin Liu Wenchang Li Qinbing Wang Wei Huang Junwei Gu Xiaoyan Fei Zhongmin Wang Xiaoyi Ding Zhiyang Wu;Wei Wu;Cheng Tao;Qin Liu;Wenchang Li;Qinbing Wang;Wei Huang;Junwei Gu;Xiaoyan Fei;Zhongmin Wang;Xiaoyi Ding

作者机构：Department of Interventional RadiologyRujin HospitalShanghai Jiao Tong University School of MedicineShanghai200025China Department of GastroenterologyRujin HospitalShanghai Jiao Tong Universiy School of MedicineShanghai200025China Department of RadiologyUniversity of Pttsburgh School of MedicinePittsburgh15213PennsylvaniaUSA Shanghai Clinical Research Center Member for Interventional MedicineChina 

出 版 物：《Journal of Interventional Medicine》 (介入医学杂志（英文）)

年 卷 期：2022年第5卷第3期

页      面：138-142页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：funded by the National Natural Science Foundation of China(62173223) Shanghai Municipal Key Clinical Specialty(grant number shslczdzk06002) Shanghai Clinical Research Center for Interventional Medicine(19MC1910300) 

主　　题：Gastric varices Gastrorenal shunt Balloon-occluded retrograde transvenous obliteration Sclerotherapy 

摘      要：Objectives:To evaluate the safety and efficacy of balloon-occluded retrograde transvenous obliteration(BRTO)using lauromacrogol sclerosant foam for gastric varices(GVs)with gastrorenal venous ***:Data of GV patients treated with BRTO using lauromacrogol sclerosant foam in 2016–2020 were retrospectively analyzed along with procedural success rate,complications,and follow-up ***:A total of 31 patients were treated with *** sclerosant foam was prepared by mixing iodinated oil,lauromacrogol,and air at a 1:2:3 *** BRTO procedure was successfully completed in 93.5%of *** patient was allergic to the lauromacrogol injection.A mild postoperative fever occurred in three *** patient experienced grand mal seizures after the *** was no significant difference in the median Child-Turcotte-Pugh scores before versus after *** GV resolution was observed in 93.1%of *** patient underwent endoscopic treatment for the development of high-risk esophageal *** patient underwent transjugular intrahepatic portosystemic shunt placement for the aggravation of ***:Lauromacrogol sclerosant foam is safe and effective in patients undergoing BRTO for GV.